Is Rocuronium in shortage right now?

Yes. FDA currently lists Rocuronium in shortage, with the reason given as "demand increase for the drug". This page is rebuilt every morning from FDA's shortage database.

Who makes Rocuronium?

3 companies have marketed Rocuronium in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

What does Rocuronium cost?

The typical pharmacy pays about $0.3942 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Market view

rocuronium

4 marketed package NDCs · 3 active manufacturers

Most dispensed: BROMIDE 50 mg/5mL · Injection, Solution · #10 vials/carton / 5 ml in 1 vial

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 25% over the past year, to $0.3942 per mL. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

Latest · Sep 2026 — typical price $0.3942 · middle half $0.3942–$0.3942 · full range $0.3942–$0.3942 · 1 products · 3 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per mLⓘSource: CMS NADAC

ⓘ How this was built

Data sources

CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
CMS Federal Upper Limit files (weighted AMP)
FDA NDC Directory (openFDA) — maker roster

Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Same drug class

Other molecules FDA puts in Nondepolarizing Neuromuscular Blocker, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Rocuronium in shortage right now?: Yes. FDA currently lists Rocuronium in shortage, with the reason given as "demand increase for the drug". This page is rebuilt every morning from FDA's shortage database.
Who makes Rocuronium?: 3 companies have marketed Rocuronium in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Rocuronium cost?: The typical pharmacy pays about $0.3942 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

In shortage now — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)Feb 15, 2023
In shortage now — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)Feb 15, 2023

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.